Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk‐prediction model

S. Tokez,M. Alblas,T. Nijsten,L.M. Pardo,M. Wakkee
DOI: https://doi.org/10.1111/bjd.18810
IF: 11.113
2020-02-26
British Journal of Dermatology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Patients with actinic keratosis (AK) are at increased risk for developing keratinocyte carcinoma (KC) but predictive factors and their risk rates are unknown.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>To develop and internally validate a prediction model to calculate the absolute risk of a first KC in AK patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>The risk prediction model was based on the prospective population‐based Rotterdam Study cohort. We hereto analyzed data of participants with at least 1 AK‐lesion at cohort baseline using a multivariable Cox proportional hazards model and included 13 a priori defined candidate predictor variables considering phenotypic, genetic and lifestyle risk factors. KCs were identified by linkage of the data with the Dutch Pathology Registry.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Of the 1,169 AK‐participants at baseline, 176 (15.1%) developed a KC after a median follow‐up of 1.8 years. The final model with significant predictors was obtained after backward stepwise selection and comprised the presence of 4‐9 AKs (hazard ratio (HR): 1.68, 95% confidence interval (CI): 1.16‐2.42), 10 or more AKs (HR: 2.43, 95% CI: 1.64‐3.61), AK‐localization on upper extremities (HR: 0.75, 95% CI: 0.52‐1.08) or elsewhere except the head (HR: 1.40, 95% CI: 0.98‐2.01), and coffee consumption (HR: 0.92, 95% CI: 0.84‐1.01). Evaluation of the discriminative ability of the model showed a bootstrap validated c‐index of 0.60.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>We showed that the risk of KC in patients with AK can be calculated with the use of four easily assessable predictor variables. Given the c‐index, extension of the model with additional, currently unknown predictor variables is desirable.</p></section>
dermatology
What problem does this paper attempt to address?